Utility of Xiralite Fluorescence Imaging System *4in patients with rheumatoid arthritis

Utility of Xiralite Fluorescence Imaging System *4in patients with rheumatoid arthritis - Utility of Xiralite

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013592

Enrollment

100

Registered

2014-05-01

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

I perform an intravenous injection of ICG and evaluate arthritis of both hands using Xiralite.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.The patients with RA visiting in our hospital (hospitalization and outpatient) 2.The patients that agree participation of clinical study

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Association with ultrasound and Xiralite in joint assessment of RA patients	—

Secondary

Measure	Time frame
Association with the image findings and blood biomarkers	—

Countries

Japan

Contacts

Public ContactShinya Kawashiri

Nagasaki University Hospital Department of Immunology and Rheumatology Nagasaki University Graduate School of Biomedical Sciences

shin-ya@nagasaki-u.ac.jp095-819-7067

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026